Asia-Pacific antimicrobial susceptibility testing market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of an Increase in the number of infectious diseases, technological advancements in antimicrobial susceptibility methods, Increased funding, research grants, and public-private investments. Other factor propelling market growth Includes the emergence of multidrug resistance due to drug abuse.

The key market players for Asia-Pacific antimicrobial susceptibility testing market are listed below;

bioM?rieux SA
Thermo Fisher Scientific
BD
Bio-Rad Laboratories, Inc.
HiMedia Laboratories.
Liofilchem S.r.l.
Accelerate Diagnostics, Inc.
Alifax Holding S.p.A.
Merck & Co., Inc.
Bioanalyse Tibbi Mal. Singing and Tic. Ltd. Sti.
Creative Diagnostics.
Genefluidics, Inc.
Conda,
Zhuhai DL Biotech. Co.


The Asia-Pacific antimicrobial susceptibility testing market is segmented into;
Product
Methods
Application
End User

On the basis of product the Asia-Pacific antimicrobial susceptibility testing market is categorized into manual and automated. In 2018, manual segment is expected to dominate the Asia-Pacific antimicrobial susceptibility testing market with the highest market share in the forecast period 2018 to 2025.
On the basis of methods Asia-Pacific antimicrobial susceptibility testing market is segmented into dilution methods, disk diffusion method, E-test, genotypic methods, automated systems. In 2018, disk diffusion method segment is expected to dominate the Asia-Pacific antimicrobial susceptibility testing market with the highest market share in the forecast period 2018 to 2025.
On the basis of application Asia-Pacific antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology, others. In 2018, clinical diagnostics segment is expected to dominate the Asia-Pacific antimicrobial susceptibility testing market with the highest CAGR in the forecast period 2018 to 2025.
On the basis of end user the Asia-Pacific antimicrobial susceptibility testing market is segmented into hospitals, pharmaceutical and biotechnology companies, diagnostic laboratories, research and academic institutes, contract research organizations. In 2018, hospitals segment is expected to dominate the Asia-Pacific antimicrobial susceptibility testing market with 33.3% market share in the forecast period 2018 to 2025.
Based on geography, the market is segmented into;
Japan
China
India
South Korea
Australia
Singapore
Thailand
Malaysia
Indonesia
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific antimicrobial susceptibility testing market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.